MedTrace Logo

A ProspeCtive mUlticenteR Investigation on RENzar Stent Safety and Efficacy in the Treatment of Patients With Femoro-popliteal Disease in Tuscany (CURRENT Registry)

NCT05701293 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-07-20

No results posted yet for this study

Summary

CURRENT Registry is a physician-initiated prospective, multicenter, post-market, single-arm study with a plan to include approximately 100 patients eligible to be treated with RenzanTM Peripheral Stent System.

Conditions

  • Peripheral Arterial Disease

Interventions

PROCEDURE

Endovascular implantation of Renzan Stent

Endovascular treatment of LEAD patients with Renzan Stent

Sponsors & Collaborators

  • University of Florence

    collaborator OTHER

  • Azienda Ospedaliera Universitaria Senese

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-01
Primary Completion
2023-12-01
Completion
2026-12-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05701293 on ClinicalTrials.gov